Peter W. Sonsini - Insider Trading & Ownership

Entity
Individual
Location
2855 Sand Hill Road, Menlo Park, CA
Summary
The estimated net worth of Peter W. Sonsini is at least $149M dollars as of December 22, 2022. Peter W. Sonsini is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146M. Peter W. Sonsini is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $1.92M. Peter W. Sonsini is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Peter W. Sonsini is the Director of Robinhood Markets, Inc. and owns shares of Robinhood Markets, Inc. (HOOD) stock worth about $3.32K. Peter W. Sonsini is the 10%+ Owner of Eargo, Inc. and owns shares of Eargo, Inc. stock worth about $2.13K. Peter W. Sonsini is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $925. Peter W. Sonsini is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $663. Peter W. Sonsini is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $360. Peter W. Sonsini is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. (DM) stock worth about $40.00.
All Insider Reports
All Insider Reports

Ownership of Peter W. Sonsini

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146M Jun 28, 2021
TRVI Trevi Therapeutics, Inc. 10%+ Owner $1.92M Apr 11, 2022
MTCR Metacrine, Inc. 10%+ Owner $1.2M Dec 10, 2021
HOOD Robinhood Markets, Inc. Director $3.32K May 2, 2022
EAR Eargo, Inc. 10%+ Owner $2.13K May 24, 2021
IONQ, IONQ-WT IonQ, Inc. 10%+ Owner $925 Nov 16, 2022
ACLX Arcellx, Inc. 10%+ Owner $663 Dec 20, 2022
AVEO AVEO PHARMACEUTICALS, INC. 10%+ Owner $360 Oct 19, 2022
DM Desktop Metal, Inc. 10%+ Owner $40.00 Jun 8, 2021
AKUS Akouos, Inc. 10%+ Owner Nov 30, 2022
NEUE NeueHealth, Inc. 10%+ Owner Oct 17, 2022
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner May 24, 2022

Insider Transactions Reported by Peter W. Sonsini:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.